Creative Protein Frontier
Latest round
- Series A
Last raised
- Jan 2023
Total raised
- $15M
Investors
- 4
About Creative Protein Frontier
Established in 2020 and based in Shanghai, China, Creative Protein Frontier operates as a protein raw materials and reagents developer that provides new drugs, diagnostics, vaccines and cell therapy. The company has laboratories and R&D centers located in Shanghai, Suzhou and Beijing. In August 2021, it cooperated with IsoPlexis to establish laboratory located in Shanghai., Ltd. became the strategic partner of the company. Yifei Wu, is the founder and CEO of the company, and once served as the executive director of protein sciences of CMC and WuXi AppTec. The company adopts computer simulation, artificial intelligence and protein preference combination CFPS (cell free protein selective) technologies, and provides protein raw materials and reagents. Its products are divided into biological reagents and detection reagents. Biological reagents include recombinant trypsin, universal nuclease, tumor necrosis factor alpha and recombinant Tth DNA polymerase. Detection reagents provides clinical diagnostics and product solutions, including early tumor diagnosis, personalized drug guidance, targeted drug use and concomitant diagnosis. The company also provides protein customization services about protein expression systems.
Who invested in Creative Protein Frontier
4 investors across 2 rounds
See all investors in Creative Protein Frontier
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Creative Protein Frontier
Who invested in Creative Protein Frontier?
Creative Protein Frontier has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Creative Protein Frontier raised?
Creative Protein Frontier has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Creative Protein Frontier last raise money?
Creative Protein Frontier's most recent round on record is a Series A, in Jan 2023.
What does Creative Protein Frontier do?
Established in 2020 and based in Shanghai, China, Creative Protein Frontier operates as a protein raw materials and reagents developer that provides new drugs, diagnostics, vaccines and cell therapy.
Where is Creative Protein Frontier headquartered?
Creative Protein Frontier is headquartered in Shanghai, China.
Which VCs invest in companies like Creative Protein Frontier?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Creative Protein Frontier's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Creative Protein Frontier? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.